Dow Jones CLOSING Averages
Dow Jones2026/11/04 21:30Dow Jones CLOSING Averages
Number of Stocks | Index Label | Price | Up/Down | Net Change | Percent Change 30 INDUS 53,356.12 UP 1,569.40 OR 3.03% 20 TRANSP 20,830.98 UP 231.30 OR 1.12% 15 UTILS 1,113.69 UP 0.97 OR 0.09% 65 STOCKS 16,777.94 UP 368.98 OR 2.25%
(END) Dow Jones Newswires
November 04, 2026 16:30 ET (21:30 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
CleanSpark presents fully funded Sandersville project in investor presentation
Forge Nano completes acquisition of HzO
Crypto prices
More
